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Synopsis
Incomplete ﬂuid suppression on ﬂuid-attenuated inversion-recovery I l  i  i   i  i i  Na-MRI ( IR-I  ( I Na-MRI)  was observed in threeI)    i  
patients undergoing IR-i  i  I Na-MRI after gadolinium contrast inject ion,  as part of  a brain tumour imaging study.  ToI   l i i   i j i ,      i   i i  .  
evaluate this,  l  i ,  Na-MRI TI   maps were acquired before and after inject ion of a gadolinium-based contrast agent on a   i     i j i    l i i     
grade IV gl ioma (GBM) patient,  which showed a statist ical ly s igniﬁcant change of  I  l i  ( )  i ,  i    i i l l  i i    Na-MRI TI   within the peritumoral i i   i l
oedema (p=0.0095).  Gadolinium contrast-enhanced  ( . ) .  l i i   Na-MRI could potential ly  add further applications for sodiumI l  i l l    l i i   i
imaging and probe tumour t issue structure in new ways to investigate prol i feration and treatment response.i i     i   i     i i  l i i    .
Introduction
Gadolinium-based contrast agents (Gad) are commonly used for the diagnosis and monitoring of changes in perfusion and blood-brain barrier
integrity in neurological conditions using clinical H-MRI. It has previously been demonstrated that Gad can alter Na chemical shift.  The eﬀect
is however small compared to dedicated Na chemical shift reagents that can be utilized to separate intra and extracellular sodium. Separation
of intra and extracellular sodium is of clinical interest, however dedicated Na contrast agents are based on heavy metals and are toxic in
humans. Triple quantum ﬁltered (TQF) Na-MRI is the gold standard for separating intra from extracellular sodium using MRI, but is limited by
low resolution and long acquisition times.  In vivo studies have recently employed inversion-recovery sodium ﬂuid attenuation (IR- Na-MRI),
due to its ease of implementation and short acquisition times compared to TQF.
However, the eﬀect of Gad on these IR sequences is unknown. This study has assessed the eﬀects of clinical concentrations of Gad in IR- Na-
MRI of brain tumors.
Methods
Three patients with brain tumors (2 glioblastoma (GBM), 1 metastases) were imaged between 15 and 60 minutes after Gadobutrol (Bayer
Schering Pharma AG, Berlin, Germany) injection on a 3T GE MR750 (GE Healthcare, Waukesha, WI) using a dual-tuned H/ Na volume head coil
(Rapid Biomed, Germany) using a 3D-cones sequence  (TE=0.5ms, TR=112-130ms,resolution=3.75mm isotropic, 30cm FOV, 500µs hard-pulse
excitation, adiabatic inversion pulse with TI=30ms, 3 averages, total scan time 12-15.5 minutes). One GBM patient was scanned before and after
Gad injection (1 mmol/kg) in addition with 4 inversion times (TI=0,20,30,40ms) for T  estimation using a shorter lower resolution protocol to
make the total scan duration clinically feasible (TE=0.5ms, TR=100ms, resolution=4.5mm isotropic, 30 cm FOV, 500µs hard-pulse excitation,
adiabatic inversion pulse, 3 averages, total scan time per TI = 1.5 minutes). This patient study is ongoing. Na-T  maps were ﬁtted in Matlab
2016a (the MathWorks, Natick, MA).  Regions-of-interest (ROIs) were drawn in Osirix 8 (Pixmeo SARL, Switzerland) by a neuroradiologist on
contrast-enhanced H T -weighted images (3D, magnetization prepared FSPGR, TE=3.18ms, TR=8.16 ms, resolution=1.5mm isotropic,
reconstructed to 1mm, 25cm FOV, 5.5 minutes). Na-MRI was co-registered to the contrast-enhanced H-T -weighted volume using SPM12
(UCL, London, UK). Statistical signiﬁcance was assessed using the paired sample t-test at the 5% signiﬁcance level.
Results
Figure 1 shows incomplete ﬂuid suppression in the patients in IR- Na-MR images after Gad injection. Residual sodium signal is detected in the
necrotic/cystic region. Images show successful suppression of cerebrospinal ﬂuid. Figure 2 shows post-contrast H-T -weighted imaging of the
patient who had Na T  maps acquired before and after gadolinium injection. White matter (40 ± 5.5 vs. 45 ± 7 ms), enhancing tumor (30 ± 2 vs.
29 ± 1 ms) and gray matter (30 ± 3 vs. 32 ± 4.5 ms) Na-T  values were similar before and after contrast injection and showed no statistically
signiﬁcant change. Within the edema however, Na-T  was signiﬁcantly reduced from 31.5 ± 1.5 to 27 ± 1 ms after contrast injection (p =
0.0095).
Discussion
We expected to see the largest eﬀect of Na-T  shortening in the enhancing part of the lesion and the necrotic/cystic core, as in the latter,
gadolinium would slowly diﬀuse and essentially be trapped. As this GBM atypically lacked a necrotic/cystic core, we were unable to test this
hypothesis and no Na-T  changes were observed in the enhancing tumor. Na-T  shortening was observed in peritumoral edema only, which
normally would not enhance on H-MRI. This eﬀect is interesting and could be due to the atypical patient or a diﬀerent eﬀect of gadolinium in
Na-T  compared to H-T . We are currently investigating in a wider pool of patients. Na-T  changes were also observed in the white matter
ROI, albeit were not statistically signiﬁcant. The white matter ROI was placed in the centrum semiovale and could have been inﬂuenced by
partial volume from ventricular cerebrospinal ﬂuid.
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Conclusion
It was shown that a Gadolinium-based contrast agent alters Na-T  relaxivity in peritumoral edema. Further subjects will be studied to
investigate the eﬀect on large necrotic/cystic regions as well as the relationship between time of injection and imaging. Investigation of other
gadolinium formulations at diﬀerent concentrations and charge distribution may demonstrate other eﬀects. More pronounced eﬀects may be
observed at higher ﬁeld strengths.
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Top row: Contrast enhanced H-T  imaging of a temporal lobe GBM on the left, ﬂuid suppressed Na-MR on the right showing a strong signal in
the necrotic/cystic part of the lesion. Middle row: Contrast enhanced H-T  imaging of a high grade serous carcinoma metastases on the left,
ﬂuid suppressed Na-MR on the right also demonstrating a strong signal in the necrotic/cystic part of the lesion. Bottom row: Contrast
enhanced H-T  imaging of a occipital/parietal lobe GBM on the left, ﬂuid suppressed Na-MR on the right showing a strong signal in the
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Contrast-enhanced H-T -weighted imaging of GBM patient showing position and extent of lesion. Na-MRI-T  maps of the same patient on the
right pre (top) and post (bottom) contrast injection. Scale bar in milliseconds.
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